North Texas Regional AONN+ Navigator Network February Dinner Meeting
Perry's Steakhouse & Grille
2100 Olive Street
Dallas, TX 75201
Tuesday, February 11, 2025 at 6:00pm CT - 8:00pm CT
Add this event to your calendar
Info
Topic
Fruzaqla: The First and Only Novel Targeted Therapy Approved for mCRC, Regardless of Mutation Status, in More Than a Decade
Attachments
Additional Information
FRUZAQLA is indicated for the treatment of adult patients with metastatic colorectal cancer (mCRC) who have previously been treated with fluoropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapy, an anti-VEGF therapy, and, if RAS wild-type and medically appropriate, an anti-EGFR therapy.
Speakers
Chief, GI Medical Oncology Houston Methodist Cancer Center
Interested In Attending This Event?
Registration Information:
Please RSVP by February 5th, 2025 to Jaime White either by phone: (817) 661-9215 or email: Jaime.White@Takeda.com
Preference will be given to Navigators, but encourage all interested to RSVP.